|
MPHOSPH8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.72090033731831E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.92930038401107E-10 |
| Normal-vs-Stage2 |
4.737900E-03 |
| Normal-vs-Stage3 |
1.10460000035673E-07 |
| Normal-vs-Stage4 |
3.57200000000724E-05 |
| Stage1-vs-Stage2 |
7.853000E-01 |
| Stage1-vs-Stage3 |
7.929000E-01 |
| Stage1-vs-Stage4 |
7.405600E-01 |
| Stage2-vs-Stage3 |
7.002600E-01 |
| Stage2-vs-Stage4 |
6.841600E-01 |
| Stage3-vs-Stage4 |
8.469800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.97559968384553E-10 |
| Normal-vs-AfricanAmerican |
1.54168999999538E-05 |
| Normal-vs-Asian |
4.36989999996751E-06 |
| Caucasian-vs-AfricanAmerican |
3.350400E-01 |
| Caucasian-vs-Asian |
5.219600E-02 |
| AfricanAmerican-vs-Asian |
2.105600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.06640277006431E-11 |
| Normal-vs-Female |
1.192580E-04 |
| Male-vs-Female |
2.145700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.74419999951792E-07 |
| Normal-vs-Extreme_Weight |
1.60370050572567E-10 |
| Normal-vs-Obese |
2.92000000001735E-06 |
| Normal-vs-Extreme_Obese |
4.34660000003806E-06 |
| Normal_Weight-vs-Extreme_Weight |
5.630600E-01 |
| Normal_Weight-vs-Obese |
3.222800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.793600E-01 |
| Extreme_Weight-vs-Obese |
7.180200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.317400E-01 |
| Obese-vs-Extreme_Obese |
3.013200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.16639999997648E-06 |
| Normal-vs-Age(41-60Yrs) |
5.28489999984671E-07 |
| Normal-vs-Age(61-80Yrs) |
1.60349511446611E-11 |
| Normal-vs-Age(81-100Yrs) |
1.01239999994451E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.863400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.880000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.099000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.057870E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.428750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.868800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.22109997061182E-10 |
| Normal-VS-Type2 PRCC |
1.76199999035731E-09 |
| Normal-VS-KIRP CIMP |
3.50859999997954E-06 |
| Normal-VS-Unclassified PRCC |
4.042400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.604400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.665600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.614800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.934600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.438600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.137800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.43645120640213E-13 |
| Normal-vs-N1 |
2.020600E-04 |
| Normal-vs-N2 |
4.22820000000046E-05 |
| N0-vs-N1 |
1.255780E-01 |
| N0-vs-N2 |
4.118200E-01 |
| N1-vs-N2 |
2.148800E-01 |
|
|
